title: Endothelin antagonists and hypertension: a question of dose?
authors.forename: Jane
authors.initials: J
authors.lastname: Goddard
authors.forename: David J
authors.initials: DJ
authors.lastname: Webb
mesh_terms: D065128:Endothelin Receptor Antagonists; D005542:Forearm / Q000098:blood supply; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D007189:Indans / Q000008:administration & dosage* / Q000494:pharmacology; D007261:Infusions, Intra-Arterial; D010456:Peptides, Cyclic / Q000008:administration & dosage* / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
chemical_list: D065128:Endothelin Receptor Antagonists; D007189:Indans; D010456:Peptides, Cyclic; C087551:1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-; C072247:cyclo(Trp-Asp-Pro-Val-Leu)